CUVITRU is a ready-to-use liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
CUVITRU is a ready-to-use liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
PATIENT RESOURCES
Learning as much as you can goes a long way in helping you manage primary immunodeficiency (PI). Here you'll find resources to help you better understand different aspects of your CUVITRU treatment and living with PI.
Watch the video to learn more about how to administer CUVITRU.
Download a complete step-by-step guide on how to infuse CUVITRU
The following organizations can connect you with information and resources to help you manage life with PI.
Immune Deficiency Foundation (IDF)
Founded in 1980, IDF is a national non-profit organization dedicated to improving the diagnosis, treatment, and quality of life of people with PI.
Jeffrey Modell Foundation (JMF)
A global patient organization devoted to early and precise diagnosis, meaningful treatments, and, ultimately, cures through research, education, support, and advocacy.
International Patient
Organisation for Primary Immunodeficiencies (IPOPI)
An organization dedicated to PI research and awareness on a global level.
American Academy of Allergy Asthma & Immunology (AAAAI)
A resource that can help you find an immunologist.
Clinical Immunology Society (CIS)
This organization facilitates educational, translational research, and novel approaches to therapy in clinical immunology.
Get more information about CUVITRU.
Sign up for emailsTalking to your doctor about your PI treatment?
Know what to ask